By Deena Beasley July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U.S. Food and Drug ...

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Once attention exists, you have the opportunity to explain the mission, communicate the science clearly, build trust and ...

Overview: Vertex leads the list with a $120B market cap, $12.95B–$13.1B revenue guidance, and strong growth from ALYFTREK and CASGEVY, reinforcing its biotech d ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

VERAXA Biotech (NASDAQ: VRXA) announced the appointment of Christoph Erkel, Ph.D., as chief scientific officer, ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.